Stuttgart
27.06.25 | 08:00
0,018 Euro
0,00 % 0,000
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,018 | 0,027 | 12:53 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Preveceutical Medical Inc: Preveceutical to hold AGM Aug. 15 | 1 | Stockwatch | ||
| PREVECEUTICAL MEDICAL Aktie jetzt für 0€ handeln | |||||
| Mi | PreveCeutical Medical Inc.: PreveCeutical Announces Date for Annual General and Special Meeting | 105 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has... ► Artikel lesen | |
| 12.06. | Preveceutical Medical Inc: Preveceutical arranges $750,000 private placement | 5 | Stockwatch | ||
| 11.06. | PreveCeutical announces non-brokered private placement | 1 | Seeking Alpha | ||
| 11.06. | PreveCeutical Medical Inc.: PreveCeutical Announces Non-Brokered Private Placement | 371 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 11, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered... ► Artikel lesen | |
| 02.06. | Preveceutical Medical Inc: Preveceutical appoints Sampath as corporate adviser | 5 | Stockwatch | ||
| 02.06. | PreveCeutical Medical Inc.: PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor | 195 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"), a health sciences company that develops... ► Artikel lesen | |
| 26.05. | Preveceutical Medical Inc: Preveceutical appoints Glover as corporate adviser | 2 | Stockwatch | ||
| 26.05. | PreveCeutical Medical Inc.: PreveCeutical Welcomes Stephen Glover as Corporate Advisor | 368 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 26, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops... ► Artikel lesen | |
| 23.05. | Preveceutical Medical Inc: Preveceutical closes $748,383 private placement | 3 | Stockwatch | ||
| 22.05. | PreveCeutical Medical Inc.: PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement | 421 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 22, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, following... ► Artikel lesen | |
| 14.05. | PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies | 348 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - May 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical"), a health sciences company that develops innovative... ► Artikel lesen | |
| 29.04. | Preveceutical Medical Inc: Preveceutical Medical closes first tranche of financing | 5 | Stockwatch | ||
| 28.04. | PreveCeutical Medical Inc.: PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement | 474 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further... ► Artikel lesen | |
| 15.04. | Preveceutical Medical Inc: Preveceutical further increases placement to $700,000 | 3 | Stockwatch | ||
| 15.04. | PreveCeutical Medical Inc.: PreveCeutical Announces Up-Sized Non-Brokered Private Placement | 552 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that, further to its news... ► Artikel lesen | |
| 03.04. | Preveceutical Medical Inc: Preveceutical increases private placement to $500,000 | 2 | Stockwatch | ||
| 03.04. | PreveCeutical Medical Inc.: PreveCeutical Announces Update to Non-Brokered Private Placement | 561 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - April 2, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce a non-brokered... ► Artikel lesen | |
| 11.03. | Preveceutical Medical Inc: Preveceutical Medical extends private placement | 4 | Stockwatch | ||
| 10.03. | PreveCeutical Medical Inc.: PreveCeutical Announces Update to Private Placement | 602 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 10, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), announces that further to its news... ► Artikel lesen |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,410 | +0,52 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.06.2025 /... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 47,830 | -0,46 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,450 | -0,83 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Neutral" belassen. Die Bayern gehörten im europäischen Medtech-Bereich... ► Artikel lesen | |
| DRAEGERWERK | 66,80 | -0,30 % | Dräger-Aktie legt um 0,15 Prozent zu (67,10 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Dräger zur Stunde im Plus. Der jüngste Kurs betrug 67,10 Euro. Das Wertpapier von Dräger verzeichnet aktuell ein Kursplus von 0,15 Prozent. Es... ► Artikel lesen | |
| MEDTRONIC | 73,83 | +0,22 % | Kaum Impulse für die Medtronic plc-Aktie (73,7742 €) | Der Kurs der dem Anteilsschein von Medtronic plc kommt kaum von der Stelle. Das Papier kostete zuletzt 85,73 US-Dollar. Die Wertschätzung der privaten und institutionellen Anlegern für die Aktie von... ► Artikel lesen | |
| INTUITIVE SURGICAL | 460,00 | +0,79 % | Intuitive Surgical Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| TELADOC HEALTH | 6,933 | +0,74 % | Aktien-Trading 4 Dummies - 3 Aktien. 2 Experten. 0 Langeweile (Hims & Hers, Teladoc & XTI Aerospace) | ||
| THERMO FISHER | 351,60 | -0,17 % | Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply | Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| FAMICORD | 4,220 | 0,00 % | Original-Research: FamiCord AG (von Montega AG): Kaufen | Original-Research: FamiCord AG - von Montega AG 06.06.2025 / 17:08 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den Inhalt der Mitteilung... ► Artikel lesen | |
| PROGYNY | 21,460 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
| PROCEPT BIOROBOTICS | 58,63 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,000 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
| ADAPTHEALTH | 9,420 | 0,00 % | AdaptHealth Corp. - 10-K/A, Annual Report | ||
| PHETON | 17,540 | 0,00 % | Pheton Holdings Ltd - S-8, Securities to be offered to employees in employee benefit plans |
Das Unternehmen PREVECEUTICAL MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,018 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PREVECEUTICAL MEDICAL INC finden Sie auf Wallstreet Online.